These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11350675)

  • 1. Cutaneous lesions in hereditary haemorrhagic telangiectasia: successful treatment with the tunable dye laser.
    Dave RU; Mahaffey PJ; Monk BE
    J Cutan Laser Ther; 2000 Dec; 2(4):191-3. PubMed ID: 11350675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of the skin manifestations of hereditary hemorrhagic telangiectasia with pulsed dye laser.
    Halachmi S; Israeli H; Ben-Amitai D; Lapidoth M
    Lasers Med Sci; 2014 Jan; 29(1):321-4. PubMed ID: 23681198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diode laser treatment and clinical management of multiple oral lesions in patients with hereditary haemorrhagic telangiectasia.
    Favia G; Tempesta A; Limongelli L; Suppressa P; Sabbà C; Maiorano E
    Br J Oral Maxillofac Surg; 2016 May; 54(4):379-83. PubMed ID: 26360009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hemorrhagic telangiectasia-laser treatment of epistaxis.
    Poje G; Kavanagh MM
    Ear Nose Throat J; 2017 Sep; 96(9):E10-E14. PubMed ID: 28931195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nd:YAG laser treatment of recurrent epistaxis in heredity hemorrhagic telangiectasia.
    Velegrakis GA; Prokopakis EP; Papadakis CE; Helidonis ES
    J Otolaryngol; 1997 Dec; 26(6):384-6. PubMed ID: 9438937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary benign telangiectasia: a rare form of primary telangiectasia with successful treatment with flash-lamp-pumped pulsed dye laser].
    Grenz H; Peschen M; Wiek K; Schöpf E; Vanscheidt W
    Vasa; 1998 Aug; 27(3):192-5. PubMed ID: 9747159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin and mucosal telangiectatic lesions in hereditary hemorrhagic telangiectasia patients.
    Hyldahl SJ; El-Jaji MQ; Schuster A; Kjeldsen AD
    Int J Dermatol; 2022 Dec; 61(12):1497-1505. PubMed ID: 35792874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia.
    Vorselaars VMM; Hosman AE; Westermann CJJ; Snijder RJ; Mager JJ; Goumans MJ; Post MC
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Harvey RJ; Kanagalingam J; Lund VJ
    Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser photocoagulation in hereditary hemorrhagic telangiectasia.
    Parkin JL; Dixon JA
    Otolaryngol Head Neck Surg; 1981; 89(2):204-8. PubMed ID: 6787514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years.
    Krings T; Ozanne A; Chng SM; Alvarez H; Rodesch G; Lasjaunias PL
    Neuroradiology; 2005 Oct; 47(10):711-20. PubMed ID: 16136265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents.
    Folz BJ; Zoll B; Alfke H; Toussaint A; Maier RF; Werner JA
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):53-61. PubMed ID: 15976991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
    Joshi H; Woodworth BA; Carney AS
    J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: clinical presentation and anatomical distribution.
    Saleh M; Carter MT; Latino GA; Dirks P; Ratjen F
    Pediatr Neurol; 2013 Dec; 49(6):445-50. PubMed ID: 24080277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia.
    Lennox PA; Harries M; Lund VJ; Howard DJ
    J Laryngol Otol; 1997 Jan; 111(1):34-7. PubMed ID: 9292128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argon laser destruction of cutaneous telangiectatic lesions.
    Lyons GD; Owens RE; Mouney DF
    Laryngoscope; 1981 Aug; 91(8):1322-5. PubMed ID: 7196480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
    Ghaheri BA; Fong KJ; Hwang PH
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1006-9. PubMed ID: 16730547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser.
    Harries PG; Brockbank MJ; Shakespeare PG; Carruth JA
    J Laryngol Otol; 1997 Nov; 111(11):1038-41. PubMed ID: 9472572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.